• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎发病机制概述(综述)

Overview of the pathogenesis of COVID-19 (Review).

作者信息

Li Chao, He Qifang, Qian Hebu, Liu Jun

机构信息

Department of Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215001, P.R. China.

Department of Critical Care Medicine, Suzhou Ninth People's Hospital, The Affiliated Wujiang Hospital of Nantong University, Suzhou, Jiangsu 215001, P.R. China.

出版信息

Exp Ther Med. 2021 Sep;22(3):1011. doi: 10.3892/etm.2021.10444. Epub 2021 Jul 15.

DOI:10.3892/etm.2021.10444
PMID:34345293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8311250/
Abstract

At present, the pathogenesis of the novel coronavirus disease 2019 (COVID-19) has not been fully elucidated. Clinical and experimental findings from studies investigating COVID-19 have suggested that the immune-inflammatory response has a crucial role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The present article aimed to systematically review the available literature on the pathogenesis of COVID-19. Severe COVID-19 is characterized by organ dysfunction, hypercytokinemia and lymphopenia. It is assumed that the direct cytopathological damage of host cells and the dysregulated immune response caused by SARS-CoV-2 may be the primary underlying mechanisms of COVID-19. Based on the published literature, this review attempts to provide an integrated view of the immunological mechanisms and the potential pathogenesis of COVID-19, providing an in-depth summary of the host-pathogen interaction and host immune responses. It is of great importance to elucidate the possible pathogenesis of COVID-19 to determine the direction of future research.

摘要

目前,2019年新型冠状病毒病(COVID-19)的发病机制尚未完全阐明。对COVID-19进行研究的临床和实验结果表明,免疫炎症反应在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中起关键作用。本文旨在系统综述关于COVID-19发病机制的现有文献。重症COVID-19的特征是器官功能障碍、细胞因子血症和淋巴细胞减少。据推测,宿主细胞的直接细胞病理学损伤以及SARS-CoV-2引起的免疫反应失调可能是COVID-19的主要潜在机制。基于已发表的文献,本综述试图提供COVID-19免疫机制和潜在发病机制的综合观点,深入总结宿主与病原体的相互作用以及宿主免疫反应。阐明COVID-19可能的发病机制对于确定未来研究方向至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca9/8311250/4a510b1ed81d/etm-22-03-10444-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca9/8311250/fd7196186bd4/etm-22-03-10444-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca9/8311250/4a510b1ed81d/etm-22-03-10444-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca9/8311250/fd7196186bd4/etm-22-03-10444-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca9/8311250/4a510b1ed81d/etm-22-03-10444-g01.jpg

相似文献

1
Overview of the pathogenesis of COVID-19 (Review).新型冠状病毒肺炎发病机制概述(综述)
Exp Ther Med. 2021 Sep;22(3):1011. doi: 10.3892/etm.2021.10444. Epub 2021 Jul 15.
2
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.影响COVID-19患者发病机制的多种免疫因素:关于病毒传播、对抗细胞因子风暴和炎症反应的免疫治疗选择的综述
Pathogens. 2021 May 7;10(5):565. doi: 10.3390/pathogens10050565.
3
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
4
The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review.宿主遗传学在人类严重病毒感染易感性中的作用及严重 COVID-19 的宿主遗传学见解:系统评价。
Virus Res. 2020 Nov;289:198163. doi: 10.1016/j.virusres.2020.198163. Epub 2020 Sep 9.
5
Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19.严重急性呼吸综合征冠状病毒 2 感染中的细胞焦亡:揭示其在 COVID-19 免疫发病机制中的作用。
Int J Biol Sci. 2022 Sep 21;18(15):5827-5848. doi: 10.7150/ijbs.77561. eCollection 2022.
6
The Immune Response and Effectiveness of COVID-19 Therapies.新型冠状病毒肺炎免疫反应和治疗效果。
Adv Exp Med Biol. 2021;1321:115-126. doi: 10.1007/978-3-030-59261-5_10.
7
COVID-19: imbalanced cell-mediated immune response drives to immunopathology.COVID-19:失衡的细胞免疫反应导致免疫病理。
Emerg Microbes Infect. 2022 Dec;11(1):2393-2404. doi: 10.1080/22221751.2022.2122579.
8
A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.基于网络的分析揭示了维生素 D 抑制 SARS-CoV-2 感染中细胞因子风暴和病毒的机制。
Front Immunol. 2020 Dec 9;11:590459. doi: 10.3389/fimmu.2020.590459. eCollection 2020.
9
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.严重 COVID-19 中失调的干扰素反应和免疫过度激活:靶向 STATs 作为一种新的治疗策略。
Front Immunol. 2022 May 17;13:888897. doi: 10.3389/fimmu.2022.888897. eCollection 2022.
10
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.细胞因子风暴和白细胞变化在轻度和重度 SARS-CoV-2 感染中的表现:对中国 3939 例 COVID-19 患者的回顾,以及新出现的发病机制和治疗概念。
J Leukoc Biol. 2020 Jul;108(1):17-41. doi: 10.1002/JLB.3COVR0520-272R. Epub 2020 Jun 13.

引用本文的文献

1
Nsp1 stalls DNA polymerase α at DNA hairpins.Nsp1在DNA发夹结构处使DNA聚合酶α停滞。
Sci Rep. 2025 May 21;15(1):17666. doi: 10.1038/s41598-025-00982-8.
2
Preventive effect of flavor/fragrance components on SARS-CoV-2 infections.香味成分对新型冠状病毒感染的预防作用。
Curr Res Microb Sci. 2024 Dec 24;8:100335. doi: 10.1016/j.crmicr.2024.100335. eCollection 2025.
3
Dynamics of Biomarkers in COVID-19 Patients Treated with Anakinra.使用阿那白滞素治疗的COVID-19患者生物标志物的动态变化

本文引用的文献

1
Coronavirus Outbreak in Italy: Physiological Benefits of Home-Based Exercise During Pandemic.意大利的冠状病毒疫情:疫情期间居家锻炼的生理益处
J Funct Morphol Kinesiol. 2020 May 7;5(2):31. doi: 10.3390/jfmk5020031.
2
The Possibility and Cause of Relapse After Previously Recovering From COVID-19: A Systematic Review.新冠病毒病康复后复发的可能性及原因:一项系统综述
Cureus. 2020 Sep 5;12(9):e10264. doi: 10.7759/cureus.10264.
3
Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives.2019冠状病毒病的潜在治疗选择:现状、挑战及未来展望
Biomedicines. 2024 Nov 25;12(12):2690. doi: 10.3390/biomedicines12122690.
4
Post-COVID Neurocognitive Disorder and Its Relation with Interleukin: A Hospital-based Cross-sectional Study.新冠后神经认知障碍及其与白细胞介素的关系:一项基于医院的横断面研究。
Indian J Psychol Med. 2024 Jun 5:02537176241249373. doi: 10.1177/02537176241249373.
5
Nsp1 stalls DNA Polymerase α at DNA hairpins.Nsp1在DNA发夹处使DNA聚合酶α停滞。
bioRxiv. 2024 Sep 5:2024.09.03.608162. doi: 10.1101/2024.09.03.608162.
6
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19.在实验性新冠肺炎中,赖诺普利可提高肺部血管紧张素转换酶2(ACE2)水平和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒载量,并减轻炎症,但不会降低疾病严重程度。
Front Pharmacol. 2024 Jul 12;15:1414406. doi: 10.3389/fphar.2024.1414406. eCollection 2024.
7
Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome.吸入性和静脉注射皮质类固醇治疗 COVID-19 相关急性呼吸窘迫综合征的疗效比较
Pharmaceutics. 2024 Jul 18;16(7):952. doi: 10.3390/pharmaceutics16070952.
8
Management of thyroiditis in the context of Covid-19: cause-effect and beyond.2019冠状病毒病背景下的甲状腺炎管理:因果关系及其他。
Acta Endocrinol (Buchar). 2023 Oct-Dec;19(4):471-479. doi: 10.4183/aeb.2023.471. Epub 2024 Jun 24.
9
Thrombosis of the vasa vasorum of the large and medium size pulmonary artery and vein leads to pulmonary thromboembolism in COVID-19.大中型肺动脉和肺静脉的血管滋养管血栓形成导致新型冠状病毒肺炎中的肺血栓栓塞。
Autops Case Rep. 2024 May 22;14:e2024491. doi: 10.4322/acr.2024.491. eCollection 2024.
10
Incidence of Thrombosis in COVID-19 Patients Compared to Non-COVID-19 Sepsis Patients in the Intensive Care Unit.重症监护病房中COVID-19患者与非COVID-19脓毒症患者的血栓形成发生率比较。
J Clin Med. 2024 May 18;13(10):2974. doi: 10.3390/jcm13102974.
Front Pharmacol. 2020 Sep 15;11:572870. doi: 10.3389/fphar.2020.572870. eCollection 2020.
4
The role of carbon monoxide and heme oxygenase-1 in COVID-19.一氧化碳和血红素加氧酶-1在2019冠状病毒病中的作用
Toxicol Rep. 2020;7:1170-1171. doi: 10.1016/j.toxrep.2020.08.027. Epub 2020 Aug 31.
5
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.SARS-CoV-2 与其他冠状病毒与 ACE(血管紧张素转换酶)-2 作为其主要受体的相互作用:治疗意义。
Hypertension. 2020 Nov;76(5):1339-1349. doi: 10.1161/HYPERTENSIONAHA.120.15256. Epub 2020 Aug 27.
6
[Case Report] Stress induced (Takotsubo) cardiomyopathy triggered by the COVID-19 pandemic.[病例报告] 由新冠疫情引发的应激性(章鱼壶型)心肌病
Exp Ther Med. 2020 Sep;20(3):2812-2814. doi: 10.3892/etm.2020.8968. Epub 2020 Jul 7.
7
Pulmonary fibrosis in the aftermath of the COVID-19 era (Review).新冠疫情时代后的肺纤维化(综述)
Exp Ther Med. 2020 Sep;20(3):2557-2560. doi: 10.3892/etm.2020.8980. Epub 2020 Jul 9.
8
Tissue damage from neutrophil-induced oxidative stress in COVID-19.COVID-19 中中性粒细胞诱导的氧化应激导致的组织损伤。
Nat Rev Immunol. 2020 Sep;20(9):515-516. doi: 10.1038/s41577-020-0407-1.
9
Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases.生活方式、氧化应激与抗氧化剂:慢性病病理生理学中的反复作用
Front Physiol. 2020 Jul 2;11:694. doi: 10.3389/fphys.2020.00694. eCollection 2020.
10
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染:一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.